BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rahman SH, Urquhart R, Molinari M. Neoadjuvant therapy for resectable pancreatic cancer. World J Gastrointest Oncol 2017; 9(12): 457-465 [PMID: 29290916 DOI: 10.4251/wjgo.v9.i12.457]
URL: https://www.wjgnet.com/1007-9327/full/v9/i12/457.htm
Number Citing Articles
1
Timothy L. Fitzgerald, Lucas Hunter, Catalina Mosquera, Charulata Jindal, Tithi Biswas, Emmanuel Zervos, Jimmy T. Efird. A simple matrix to predict treatment success and long-term survival among patients undergoing pancreatectomyHPB 2019; 21(2): 204 doi: 10.1016/j.hpb.2018.07.010
2
Ashika D. Maharaj, Stella Samoborec, Sue M. Evans, John Zalcberg, Rachel E. Neale, David Goldstein, Neil Merrett, Kate White, Daniel Croagh, Charles H.C. Pilgrim, Peter Evans, Brett Knowles, Trevor Leong, Jennifer Philip, Marty Smith, Liane Ioannou. Patient-reported outcome measures (PROMs) in pancreatic cancer: a systematic reviewHPB 2020; 22(2): 187 doi: 10.1016/j.hpb.2019.09.002
3
Alberto Larghi, Mihai Rimbaş, StefanoFrancesco Crino, Gianenrico Rizzatti, Antonio Gasbarrini, Guido Costamagna. EUS: A one-stop shop approach for pancreatic head masses: Dream or reality?Endoscopic Ultrasound 2019; 8(4): 217 doi: 10.4103/eus.eus_61_18
4
Adriana Harbuzariu, Gabriela Oprea-Ilies, Ruben R. Gonzalez-Perez. Advances in Pancreatic Cancer2018;  doi: 10.5772/intechopen.76400
5
Hui Peng, C. Alston James, Darren R. Cullinan, Graham D. Hogg, Jacqueline L. Mudd, Chong Zuo, Rony Takchi, Katharine E. Caldwell, Jingxia Liu, David G. DeNardo, Ryan C. Fields, William E. Gillanders, S. Peter Goedegebuure, William G. Hawkins. Neoadjuvant FOLFIRINOX Therapy Is Associated with Increased Effector T Cells and Reduced Suppressor Cells in Patients with Pancreatic CancerClinical Cancer Research 2021; 27(24): 6761 doi: 10.1158/1078-0432.CCR-21-0998
6
Zoe C. Schmiechen, Ingunn M. Stromnes. Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal AdenocarcinomaFrontiers in Immunology 2021; 11 doi: 10.3389/fimmu.2020.613815
7
Feng Yang, Chen Jin, Caifeng Zou, Yang Di, Sijie Hao, Haihui Huang, Andrew L. Warshaw, Deliang Fu. Delaying surgery after preoperative biliary drainage does not increase surgical morbidity after pancreaticoduodenectomySurgery 2019; 166(6): 1004 doi: 10.1016/j.surg.2019.07.012
8
D. A. Chichevatov, V. V. Kalentjev, A. E. Glukhov. Single vein resection in surgery for pancreatic ductal carcinoma as a criterion of resectabilitySiberian journal of oncology 2022; 21(4): 25 doi: 10.21294/1814-4861-2022-21-4-25-31
9
Alberto Larghi, Mihai Rimbaş, Gianenrico Rizzatti, Giuseppe Quero, Antonio Gasbarrini, Guido Costamagna, Sergio Alfieri. Resectable pancreatic solid lesions: Time to move from surgical diagnosis?Endoscopic Ultrasound 2020; 9(2): 76 doi: 10.4103/eus.eus_67_19
10
Xinyuan Liu, Qi Zhang, Tao Mao, Congcong Min, Jing Guo, Cuiping Zhang, Zibin Tian, Xiaoyu Li. Identification of therapeutic targets and prognostic biomarkers among CC chemokines in the pancreatic adenocarcinoma microenvironmentGastroenterology & Endoscopy 2023; 1(2): 91 doi: 10.1016/j.gande.2022.11.006
11
Takahiro Yokose, Minoru Kitago, Yohji Matsusaka, Yohei Masugi, Masahiro Shinoda, Hiroshi Yagi, Yuta Abe, Go Oshima, Shutaro Hori, Yutaka Endo, Kenji Toyama, Yu Iwabuchi, Ryo Takemura, Ryota Ishii, Tadaki Nakahara, Shigeo Okuda, Masahiro Jinzaki, Yuko Kitagawa. Usefulness of 18F‐fluorodeoxyglucose positron emission tomography/computed tomography for predicting the prognosis and treatment response of neoadjuvant therapy for pancreatic ductal adenocarcinomaCancer Medicine 2020; 9(12): 4059 doi: 10.1002/cam4.3044
12
Maciej Słodkowski, Marek Wroński, Dominika Karkocha, Leszek Kraj, Kaja Śmigielska, Aneta Jachnis. Current Approaches for the Curative-Intent Surgical Treatment of Pancreatic Ductal AdenocarcinomaCancers 2023; 15(9): 2584 doi: 10.3390/cancers15092584
13
Anna Tavakkoli, Amit G. Singal, Akbar K. Waljee, James M. Scheiman, Caitlin C. Murphy, Sandi L. Pruitt, Lei Xuan, Richard S. Kwon, Ryan J. Law, Grace H. Elta, Phyllis Wright‐Slaughter, Thomas S. Valley, Nisa Kubiliun, Hari Nathan, Joel H. Rubenstein, B. Joseph Elmunzer. Regional and racial variations in the utilization of endoscopic retrograde cholangiopancreatography among pancreatic cancer patients in the United StatesCancer Medicine 2019; 8(7): 3420 doi: 10.1002/cam4.2225
14
Mariana I. Chavez. Management of Localized Pancreatic Cancer2019; : 47 doi: 10.1007/978-3-319-98944-0_5
15
Dong Xu, Kai Zhang, Mingna Li, J. P. Neoptolemos, Junli Wu, Wentao Gao, Pengfei Wu, Baobao Cai, Jie Yin, Guodong Shi, Zipeng Lu, Kuirong Jiang, Yi Miao. Prognostic Nomogram for Resected Pancreatic Adenocarcinoma: A TRIPOD‐Compliant Retrospective Long‐Term Survival AnalysisWorld Journal of Surgery 2020; 44(4): 1260 doi: 10.1007/s00268-019-05325-z
16
Khaled Y. Elbanna, Hyun-Jung Jang, Tae Kyoung Kim. Imaging diagnosis and staging of pancreatic ductal adenocarcinoma: a comprehensive reviewInsights into Imaging 2020; 11(1) doi: 10.1186/s13244-020-00861-y
17
Libing Tian, Rui Pei, Lijuan Zhong, Yuchao Ji, Danhua Zhou, Shufeng Zhou. Enhanced targeting of 3D pancreatic cancer spheroids by aptamer-conjugated polymeric micelles with deep tumor penetrationEuropean Journal of Pharmacology 2021; 894: 173814 doi: 10.1016/j.ejphar.2020.173814
18
Kyriaki Lekka, Evanthia Tzitzi, Alexander Giakoustidis, Vassilios Papadopoulos, Dimitrios Giakoustidis. Contemporary management of borderline resectable pancreatic ductal adenocarcinomaAnnals of Hepato-Biliary-Pancreatic Surgery 2019; 23(2): 97 doi: 10.14701/ahbps.2019.23.2.97
19
Mihai Rimbaș, Gianenrico Rizzatti, Alberto Larghi. Clinical Pancreatology for Practising Gastroenterologists and Surgeons2021; : 460 doi: 10.1002/9781119570097.ch57